Standard BioTools Statistics
Total Valuation
LAB has a market cap or net worth of $423.50 million. The enterprise value is $196.97 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LAB has 379.82 million shares outstanding. The number of shares has increased by 181.57% in one year.
| Current Share Class | 379.82M |
| Shares Outstanding | 379.82M |
| Shares Change (YoY) | +181.57% |
| Shares Change (QoQ) | +0.98% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 48.11% |
| Float | 239.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.46 |
| Forward PS | 2.40 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.07.
| Current Ratio | 6.12 |
| Quick Ratio | 5.22 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55.28 |
Financial Efficiency
Return on equity (ROE) is -25.73% and return on invested capital (ROIC) is -13.67%.
| Return on Equity (ROE) | -25.73% |
| Return on Assets (ROA) | -11.63% |
| Return on Invested Capital (ROIC) | -13.67% |
| Return on Capital Employed (ROCE) | -24.14% |
| Revenue Per Employee | $207,441 |
| Profits Per Employee | -$162,300 |
| Employee Count | 818 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.18 |
Taxes
In the past 12 months, LAB has paid $294,000 in taxes.
| Income Tax | 294,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.95% in the last 52 weeks. The beta is 1.80, so LAB's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | -52.95% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 47.62 |
| Average Volume (20 Days) | 1,000,158 |
Short Selling Information
The latest short interest is 17.26 million, so 4.54% of the outstanding shares have been sold short.
| Short Interest | 17.26M |
| Short Previous Month | 17.68M |
| Short % of Shares Out | 4.54% |
| Short % of Float | 7.21% |
| Short Ratio (days to cover) | 12.56 |
Income Statement
In the last 12 months, LAB had revenue of $169.69 million and -$132.76 million in losses. Loss per share was -$0.35.
| Revenue | 169.69M |
| Gross Profit | 79.82M |
| Operating Income | -126.32M |
| Pretax Income | -118.58M |
| Net Income | -132.76M |
| EBITDA | -110.48M |
| EBIT | -126.32M |
| Loss Per Share | -$0.35 |
Full Income StatementBalance Sheet
The company has $258.06 million in cash and $31.53 million in debt, giving a net cash position of $226.53 million or $0.60 per share.
| Cash & Cash Equivalents | 258.06M |
| Total Debt | 31.53M |
| Net Cash | 226.53M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 454.60M |
| Book Value Per Share | 1.20 |
| Working Capital | 287.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$111.26 million and capital expenditures -$12.63 million, giving a free cash flow of -$123.89 million.
| Operating Cash Flow | -111.26M |
| Capital Expenditures | -12.63M |
| Free Cash Flow | -123.89M |
| FCF Per Share | -$0.33 |
Full Cash Flow StatementMargins
Gross margin is 47.04%, with operating and profit margins of -74.44% and -78.24%.
| Gross Margin | 47.04% |
| Operating Margin | -74.44% |
| Pretax Margin | -78.07% |
| Profit Margin | -78.24% |
| EBITDA Margin | -65.11% |
| EBIT Margin | -74.44% |
| FCF Margin | n/a |
Dividends & Yields
LAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -181.57% |
| Shareholder Yield | -181.57% |
| Earnings Yield | -31.35% |
| FCF Yield | -29.25% |
Analyst Forecast
The average price target for LAB is $2.50, which is 124.22% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.50 |
| Price Target Difference | 124.22% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 7.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LAB has an Altman Z-Score of 0.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.69 |
| Piotroski F-Score | 3 |